Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109577223 | 10957722 | 3 | F | 20160810 | 20150326 | 20160816 | EXP | US-PFIZER INC-2015101144 | PFIZER | 65.00 | YR | M | Y | 0.00000 | 20160816 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109577223 | 10957722 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, 3X/DAY | 21446 | 100 | MG | CAPSULE, HARD | TID | ||||||
| 109577223 | 10957722 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, 2X/DAY | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | BID | ||||||
| 109577223 | 10957722 | 3 | C | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | 100 UNIT/ML SOLN 25 UNITS SQ BEFORE BED | 0 | 25 | IU | QD | ||||||||
| 109577223 | 10957722 | 4 | C | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | 15 UNITS SQ EVERY MORNING AND 25 UNITS SQ AT NIGHT | 0 | BID | ||||||||||
| 109577223 | 10957722 | 5 | C | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | 34 UNITS EVERY HS | 0 | 34 | IU | |||||||||
| 109577223 | 10957722 | 6 | C | HUMALOG | INSULIN LISPRO | 1 | 100 IU/ML, UNK | 0 | SOLUTION FOR INJECTION | ||||||||||
| 109577223 | 10957722 | 7 | C | METFORMIN HCL | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG,2X/DAY (500 MG TAB, 2 TAB TWICE A DAY) | 0 | 1000 | MG | TABLET | BID | ||||||
| 109577223 | 10957722 | 8 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG, 1X/DAY | 0 | 100 | MG | TABLET | QD | ||||||
| 109577223 | 10957722 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | TABLET | QD | ||||||
| 109577223 | 10957722 | 10 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG, 1X/DAY | 0 | 300 | MG | TABLET | QD | ||||||
| 109577223 | 10957722 | 11 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, 1X/DAY | 0 | 81 | MG | TABLET | QD | ||||||
| 109577223 | 10957722 | 12 | C | NIGHTAID | 2 | Oral | 1 DF, AS NEEDED (EVERY NIGHT AT BEDTIME AS NEEDED) | 0 | 1 | DF | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109577223 | 10957722 | 1 | Neuropathy peripheral |
| 109577223 | 10957722 | 12 | Insomnia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109577223 | 10957722 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109577223 | 10957722 | Eczema | |
| 109577223 | 10957722 | Gastrooesophageal reflux disease | |
| 109577223 | 10957722 | Haematuria | |
| 109577223 | 10957722 | Hypertension | |
| 109577223 | 10957722 | Overweight | |
| 109577223 | 10957722 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |